申请人:PFIZER INC.
公开号:EP0104860A1
公开(公告)日:1984-04-04
Certain substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones are highly potent gabaergic agents, valuable in the treatment of individuals suffering from schizophrenia or reversing the side effects of a previously or concurrently administered neuroleptic agent; or in the treatment of epilepsy. A wider class of substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones, together with 1-phenyl-3-(2-pyrrolidinylidene)-2(1H,3H)-indolones, and homologs thereof, are valuable in the treatment of anxiety.
某些取代的 1-苯基-3-(氨基亚烷基)-2(1H,3H)-吲哚酮是强效的伽巴能药物,对治疗精神分裂症患者或逆转之前或同时使用的神经安定剂的副作用,或治疗癫痫很有价值。还有一类取代的 1-苯基-3-(氨基亚烷基)-2(1H,3H)-吲哚酮,以及 1-苯基-3-(2-吡咯烷亚基)-2(1H,3H)-吲哚酮及其同系物,对治疗焦虑症很有价值。